Complete Filing Data
Lineage, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $9.24 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lineage, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$100.0M | -$664.0M | -$77.0M | -$63.0M |
| Revenue * | $5.36B | $5.34B | $5.34B | $4.93B |
| Other Comprehensive Income Loss Net Of Tax | $197.0M | -$267.0M | $1.0M | -$49.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $258.0M | -$207.0M | $88.0M | -$221.0M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$61.0M | -$60.0M | -$87.0M | $172.0M |
| Operating Income Loss | $181.0M | -$361.0M | $398.0M | $297.0M |
| Nonoperating Income Expense | -$296.0M | -$479.0M | -$508.0M | -$367.0M |
| Net Income Loss Attributable To Noncontrolling Interest | -$13.0M | -$87.0M | -$19.0M | -$13.0M |
| Interest Income Expense Nonoperating Net | -$268.0M | -$430.0M | -$490.0M | -$347.0M |
| Income Tax Expense Benefit | -$2.0M | -$89.0M | -$14.0M | $6.0M |
| Income Loss From Equity Method Investments | -$3.0M | -$6.0M | -$3.0M | $0.00 |
| General And Administrative Expense | $574.0M | $539.0M | $502.0M | $399.0M |
| Cost Of Goods And Services Sold | $3.63B | $3.58B | $3.59B | $3.47B |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $84.0M | -$1.02B | -$95.0M | -$125.0M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $8.0M | -$115.0M | -$21.0M | -$16.0M |
| Comprehensive Income Net Of Tax | $76.0M | -$903.0M | -$74.0M | -$109.0M |
| Other Nonoperating Income Expense | -$50.0M | -$1.0M | -$19.0M | $2.0M |
| Restructuring Settlement And Impairment Provisions | $57.0M | $32.0M | $15.0M | |
| Income Taxes Paid Net | $26.0M | $36.0M | $31.0M | $74.0M |
| Deferred Income Tax Expense Benefit | -$16.0M | -$105.0M | -$58.0M | -$42.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$100.0M | -$6.0M | $0.00 | -$485.0M | -$68.0M | -$40.0M | -$39.0M | -$5.0M | $19.0M |
| Revenue * | $1.38B | $1.35B | $1.29B | $1.34B | $1.34B | $1.33B | $1.33B | $1.35B | |
| Other Comprehensive Income Loss Net Of Tax | -$40.0M | $170.0M | $47.0M | $69.0M | -$25.0M | -$71.0M | -$87.0M | $39.0M | -$9.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$25.0M | $184.0M | $64.0M | $115.0M | -$12.0M | -$74.0M | -$78.0M | $19.0M | |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$15.0M | -$14.0M | -$17.0M | -$46.0M | -$13.0M | $3.0M | -$10.0M | $20.0M | |
| Operating Income Loss | $35.0M | $23.0M | $56.0M | -$515.0M | $74.0M | $101.0M | $97.0M | $111.0M | |
| Nonoperating Income Expense | -$136.0M | -$37.0M | -$48.0M | -$73.0M | -$147.0M | -$159.0M | -$152.0M | -$119.0M | |
| Net Income Loss Attributable To Noncontrolling Interest | -$12.0M | -$1.0M | $0.00 | -$58.0M | -$12.0M | -$8.0M | -$11.0M | -$3.0M | |
| Interest Income Expense Nonoperating Net | -$68.0M | -$67.0M | -$60.0M | -$82.0M | -$148.0M | -$139.0M | -$126.0M | -$116.0M | |
| Income Tax Expense Benefit | $11.0M | -$7.0M | $8.0M | -$45.0M | $7.0M | -$10.0M | -$5.0M | $0.00 | |
| Income Loss From Equity Method Investments | -$2.0M | $3.0M | -$4.0M | $0.00 | -$1.0M | -$2.0M | -$2.0M | $0.00 | |
| General And Administrative Expense | $145.0M | $143.0M | $154.0M | $143.0M | $127.0M | $124.0M | $122.0M | $124.0M | |
| Cost Of Goods And Services Sold | $932.0M | $920.0M | $876.0M | $897.0M | $891.0M | $884.0M | $899.0M | $905.0M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$152.0M | $163.0M | $47.0M | -$474.0M | -$105.0M | -$119.0M | -$138.0M | $31.0M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$16.0M | $17.0M | $5.0M | -$50.0M | -$15.0M | -$16.0M | -$21.0M | $1.0M | |
| Comprehensive Income Net Of Tax | -$136.0M | $146.0M | $42.0M | -$424.0M | -$90.0M | -$103.0M | -$117.0M | $30.0M | |
| Other Nonoperating Income Expense | -$57.0M | $1.0M | $1.0M | $0.00 | -$19.0M | ||||
| Restructuring Settlement And Impairment Provisions | $3.0M | -$21.0M | $8.0M | $15.0M | $0.00 | $4.0M | $3.0M | ||
| Income Taxes Paid Net | $1.0M | $9.0M | |||||||
| Deferred Income Tax Expense Benefit | $11.0M | -$23.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $8.25B | $8.64B | $5.05B | $5.81B | $4.93B |
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $7.0M | $43.0M | $349.0M | $298.0M | $361.0M |
| Minority Interest | $990.0M | $1.01B | $622.0M | $641.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.0M | $175.0M | $71.0M | $202.0M | $240.0M |
| Redeemable Noncontrolling Interest Equity Carrying Amount | $7.0M | $43.0M | |||
| Gains Losses On Extinguishment Of Debt | -$3.0M | -$17.0M | $0.00 | $2.0M | |
| Temporary Equity Accretion To Redemption Value | $15.0M | $36.0M | $34.0M | ||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $259.0M | $146.0M | $43.0M | ||
| Temporary Equity Redeemable Noncontrolling Interest Adjustment | -$2.0M | $23.0M | $44.0M | -$18.0M | |
| Repayments Of Long Term Debt And Capital Securities | $231.0M | $7.11B | $96.0M | $103.0M | |
| Payment For Contingent Consideration Liability Financing Activities | $6.0M | $46.0M | $36.0M | $8.0M | |
| Goodwill | $3.47B | $3.34B | $3.39B | $3.31B | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$109.0M | $104.0M | -$131.0M | -$38.0M | |
| Retained Earnings Accumulated Deficit | -$2.44B | -$1.86B | -$879.0M | ||
| Property Plant And Equipment Net | $11.34B | $10.63B | $10.57B | ||
| Prepaid Expense And Other Assets Current | $132.0M | $97.0M | $101.0M | ||
| Other Liabilities Noncurrent | $169.0M | $410.0M | $159.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $8.38B | $8.64B | $8.59B | $9.03B | $4.88B | $5.61B | $5.80B | $5.95B | $5.93B | |
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $7.0M | $7.0M | $41.0M | $39.0M | $262.0M | $256.0M | $329.0M | $320.0M | $311.0M | |
| Minority Interest | $995.0M | $1.02B | $1.02B | $1.06B | $614.0M | $630.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $75.0M | $82.0M | $197.0M | $412.0M | $76.0M | $94.0M | $112.0M | $141.0M | ||
| Redeemable Noncontrolling Interest Equity Carrying Amount | $7.0M | $7.0M | $41.0M | $39.0M | $262.0M | $256.0M | $349.0M | |||
| Gains Losses On Extinguishment Of Debt | -$3.0M | $0.00 | $0.00 | -$6.0M | $0.00 | -$7.0M | $0.00 | $0.00 | ||
| Temporary Equity Accretion To Redemption Value | $3.0M | $2.0M | $6.0M | $9.0M | $9.0M | $9.0M | ||||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $100.0M | $12.0M | $12.0M | $11.0M | $12.0M | $12.0M | ||||
| Temporary Equity Redeemable Noncontrolling Interest Adjustment | -$2.0M | $4.0M | $4.0M | $6.0M | -$6.0M | $4.0M | ||||
| Repayments Of Long Term Debt And Capital Securities | $25.0M | $972.0M | ||||||||
| Payment For Contingent Consideration Liability Financing Activities | $2.0M | $0.00 | ||||||||
| Goodwill | $3.47B | $3.51B | $3.38B | $3.44B | $3.36B | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $22.0M | $23.0M | ||||||||
| Retained Earnings Accumulated Deficit | -$2.33B | -$2.10B | -$1.98B | -$1.66B | -$987.0M | |||||
| Property Plant And Equipment Net | $11.25B | $11.32B | $10.64B | $10.67B | $10.49B | |||||
| Prepaid Expense And Other Assets Current | $183.0M | $201.0M | $171.0M | $111.0M | $137.0M | |||||
| Other Liabilities Noncurrent | $465.0M | $461.0M | $425.0M | $434.0M | $159.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Share Based Compensation | $126.0M | $215.0M | $26.0M | $17.0M |
| Proceeds From Payments For Other Financing Activities | -$5.0M | -$5.0M | -$13.0M | $3.0M |
| Proceeds From Lines Of Credit | $2.83B | $4.11B | $1.43B | $2.47B |
| Proceeds From Issuance Of Long Term Debt | $1.30B | $2.48B | $0.00 | $946.0M |
| Payments To Acquire Property Plant And Equipment | $747.0M | $691.0M | $766.0M | $813.0M |
| Payments To Acquire Businesses Net Of Cash Acquired | $443.0M | $346.0M | $283.0M | $1.64B |
| Payments Of Financing Costs | $13.0M | $45.0M | $0.00 | $9.0M |
| Payments Of Dividends | $537.0M | $234.0M | $46.0M | $180.0M |
| Payments For Repurchase Of Redeemable Noncontrolling Interest | $28.0M | $6.0M | $0.00 | $56.0M |
| Payments For Repurchase Of Common Stock | $82.0M | $42.0M | $12.0M | $0.00 |
| Payments For Proceeds From Other Investing Activities | $3.0M | -$11.0M | $5.0M | $1.0M |
| Net Cash Provided By Used In Operating Activities | $943.0M | $703.0M | $796.0M | $501.0M |
| Net Cash Provided By Used In Investing Activities | -$1.07B | -$919.0M | -$1.07B | -$2.37B |
| Net Cash Provided By Used In Financing Activities | $14.0M | $320.0M | $136.0M | $1.84B |
| Increase Decrease In Right Of Use Assets And Operating Lease Liabilities | $2.0M | $13.0M | $12.0M | $13.0M |
| Increase Decrease In Prepaid Expenses Other Assets And Other Long Term Liabilities | $11.0M | $29.0M | $12.0M | $53.0M |
| Increase Decrease In Inventories | $5.0M | $18.0M | -$8.0M | $13.0M |
| Increase Decrease In Accounts Receivable | $37.0M | -$64.0M | -$43.0M | $156.0M |
| Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue | $40.0M | -$85.0M | $51.0M | $84.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0M | $0.00 | $3.0M | -$10.0M |
| Depreciation Depletion And Amortization | $895.0M | $876.0M | $760.0M | $678.0M |
| Proceeds From Insurance Settlement Investing Activities | $51.0M | $105.0M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Share Based Compensation | $40.0M | $5.0M |
| Proceeds From Payments For Other Financing Activities | -$2.0M | -$6.0M |
| Proceeds From Lines Of Credit | $582.0M | $1.84B |
| Proceeds From Issuance Of Long Term Debt | $0.00 | $81.0M |
| Payments To Acquire Property Plant And Equipment | $151.0M | $147.0M |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $59.0M |
| Payments Of Financing Costs | $0.00 | $44.0M |
| Payments Of Dividends | $134.0M | $112.0M |
| Payments For Repurchase Of Redeemable Noncontrolling Interest | $0.00 | $6.0M |
| Payments For Repurchase Of Common Stock | $0.00 | $25.0M |
| Payments For Proceeds From Other Investing Activities | -$1.0M | -$5.0M |
| Net Cash Provided By Used In Operating Activities | $139.0M | $105.0M |
| Net Cash Provided By Used In Investing Activities | -$138.0M | -$202.0M |
| Net Cash Provided By Used In Financing Activities | $21.0M | $121.0M |
| Increase Decrease In Right Of Use Assets And Operating Lease Liabilities | $2.0M | -$2.0M |
| Increase Decrease In Prepaid Expenses Other Assets And Other Long Term Liabilities | $39.0M | $21.0M |
| Increase Decrease In Inventories | -$12.0M | -$2.0M |
| Increase Decrease In Accounts Receivable | $24.0M | -$36.0M |
| Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue | -$51.0M | -$83.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | -$1.0M |
| Depreciation Depletion And Amortization | $212.0M | $211.0M |
| Proceeds From Insurance Settlement Investing Activities | $17.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 228.0M | 191.0M | 162.0M | 152.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 228.0M | 191.0M | 162.0M | 152.0M |
| Earnings Per Share Diluted | $-0.43 | $-3.70 | $-0.73 | $-0.51 |
| Earnings Per Share Basic | $-0.43 | $-3.70 | $-0.73 | $-0.51 |
| Common Stock Dividends Per Share Declared | $2.11 | $0.91 | $0.55 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 228.0M | 229.0M | 228.0M | 210.0M | 162.0M | 162.0M | 162.0M | 162.0M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 228.0M | 229.0M | 228.0M | 210.0M | 162.0M | 162.0M | 162.0M | 162.0M | ||
| Earnings Per Share Diluted | $-0.44 | $-0.03 | $0.01 | $-2.44 | $-0.46 | $-0.28 | $-0.26 | $-0.08 | ||
| Earnings Per Share Basic | $-0.44 | $-0.03 | $0.01 | $-2.44 | $-0.46 | $-0.28 | $-0.26 | $-0.08 | ||
| Common Stock Dividends Per Share Declared | $0.53 | $0.53 | $0.53 | $0.53 | $0.53 | $0.38 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $126.0M | $215.0M | $26.0M | $17.0M |
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$115.0M | -$840.0M | -$110.0M | -$70.0M |
| Foreign Currency Transaction Gain Loss Before Tax | $28.0M | -$25.0M | $4.0M | -$24.0M |
| Costs And Expenses | $5.17B | $5.70B | $4.94B | $4.63B |
| Acquisition Transaction And Other Expenses | $67.0M | $651.0M | $60.0M | $66.0M |
| Adjustments To Additional Paid In Capital Accretion Of Redeemable Noncontrolling Interests | -$15.0M | -$36.0M | -$34.0M | |
| Stock Repurchased During Period Value | $82.0M | $76.0M | $12.0M | $4.0M |
| Repayments Of Lines Of Credit | $3.06B | $3.51B | $1.22B | $2.15B |
| Provision For Doubtful Accounts | $6.0M | $5.0M | $6.0M | $5.0M |
| Interest Paid Net | $299.0M | $523.0M | $594.0M | $354.0M |
| Insured Event Gain Loss | $58.0M | $76.0M | $0.00 | $0.00 |
| Capital Expenditures Incurred But Not Yet Paid | $87.0M | $118.0M | $104.0M | $100.0M |
| Adjustment For Amortization | $220.0M | $217.0M | $208.0M | $198.0M |
| Stock Issued During Period Value New Issues | $4.87B | $142.0M | $935.0M | |
| Adjustments To Additional Paid In Capital Redeemable Noncontrolling Interest Adjustment | $2.0M | -$23.0M | -$44.0M | $18.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $38.0M | $29.0M | $40.0M | $160.0M | $6.0M | $5.0M | $8.0M | $6.0M | $5.0M |
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$101.0M | -$14.0M | $8.0M | -$588.0M | -$73.0M | -$58.0M | -$55.0M | -$8.0M | |
| Foreign Currency Transaction Gain Loss Before Tax | -$6.0M | $26.0M | $16.0M | $14.0M | $2.0M | -$11.0M | -$5.0M | -$3.0M | |
| Costs And Expenses | $1.34B | $1.33B | $1.24B | $1.85B | $1.26B | $1.23B | $1.23B | $1.24B | |
| Acquisition Transaction And Other Expenses | $12.0M | $37.0M | $15.0M | $592.0M | $12.0M | $8.0M | $19.0M | $15.0M | |
| Adjustments To Additional Paid In Capital Accretion Of Redeemable Noncontrolling Interests | $2.0M | -$3.0M | -$2.0M | -$6.0M | -$9.0M | -$9.0M | -$9.0M | ||
| Stock Repurchased During Period Value | $28.0M | $76.0M | $25.0M | $3.0M | |||||
| Repayments Of Lines Of Credit | $398.0M | $632.0M | |||||||
| Provision For Doubtful Accounts | $1.0M | $1.0M | |||||||
| Interest Paid Net | $86.0M | $161.0M | |||||||
| Insured Event Gain Loss | $24.0M | $0.00 | |||||||
| Capital Expenditures Incurred But Not Yet Paid | $78.0M | $73.0M | |||||||
| Adjustment For Amortization | $56.0M | $54.0M | $54.0M | $54.0M | $55.0M | $53.0M | |||
| Stock Issued During Period Value New Issues | $4.87B | $1.0M | $2.0M | $140.0M | |||||
| Adjustments To Additional Paid In Capital Redeemable Noncontrolling Interest Adjustment | -$4.0M | -$4.0M | $6.0M | -$4.0M |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.